LIPOCINE INC. Shareholders' Equity
LIPOCINE INC. (LPCN) had Shareholders' Equity of $21.77 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $21.77M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $22.83M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $14.48M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $14.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $21.77M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $22.83M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $14.48M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $14.14M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $17.13M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $19.20M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $21.00M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $19.12M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $21.21M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $23.96M 10-Q · filed 2025-08-05 | |
| 2023-12-31 | $20.37M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $22.48M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $28.55M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $31.96M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $35.63M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $37.65M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $39.89M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $42.41M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $45.57M 10-K · filed 2024-03-07 | |
| 2021-09-30 | $32.81M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $35.75M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $42.39M 10-Q · filed 2022-08-08 | |
| 2020-12-31 | $15.34M 10-K · filed 2023-03-10 | |
| 2020-09-30 | $14.51M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $13.08M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $6.55M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $6.29M 10-K · filed 2022-03-09 | |
| 2019-09-30 | $7.51M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $9.85M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $12.55M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $9.43M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $11.76M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $13.88M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $16.67M 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $18.98M 10-K · filed 2020-03-13 | |
| 2017-09-30 | $23.77M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $25.15M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $24.88M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $26.02M 10-K · filed 2019-03-06 | |
| 2016-09-30 | $27.98M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $30.76M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $35.78M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $41.99M 10-K · filed 2019-03-06 | |
| 2015-09-30 | $46.25M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $52.13M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $23.72M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $26.36M 10-K · filed 2018-03-12 | |
| 2014-09-30 | $29.96M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $33.82M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $40.60M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $44.82M 10-K · filed 2017-03-06 | |
| 2013-09-30 | $35.54M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$17.63K 10-Q · filed 2013-07-09 | |
| 2013-03-31 | -$14.53K 10-Q · filed 2013-04-24 | |
| 2012-12-31 | $5.32M 10-K · filed 2015-03-11 | -$11.32K 10-K · filed 2013-02-26 |
| 2012-09-30 | -$6.37K 10-Q · filed 2012-10-26 | |
| 2011-12-31 | $1.30M 10-K · filed 2014-03-31 | $24.84K 10-Q · filed 2012-05-14 |
| 2011-10-12 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |